Meanwhile, fellow Swiss company Novartis will no longer use diverse panels in its hiring process for U.S.-based employees, ...

After bringing Zolgensma to market in 2019 as the first gene therapy for spinal muscular atrophy, Novartis is back with a ...

It’s not just American companies rethinking their diversity, equity, and inclusion (DEI) initiatives. Swiss pharma giants ...

February saw a flurry of significant hires in the agency world, with several key players making strategic appointments to bolster their leadership teams. We’ve also included consultancy and investor ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...